The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Novocure
Research Funding - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Novocure

A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.
 
Everett J Moding
No Relationships to Disclose
 
Mohammad Shahrokh Esfahani
No Relationships to Disclose
 
Barzin Nabet
Patents, Royalties, Other Intellectual Property - I have a patent pending related to immunomodulatory nucleic acids. (Inst)
 
Yufei Liu
No Relationships to Disclose
 
Jacob J. Chabon
No Relationships to Disclose
 
Jianzhong He
No Relationships to Disclose
 
Yawei Qiao
No Relationships to Disclose
 
Ting Xu
No Relationships to Disclose
 
Luyang Yao
No Relationships to Disclose
 
Saumil Gandhi
No Relationships to Disclose
 
Zhongxing X. Liao
Honoraria - Varian Medical Systems
Speakers' Bureau - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
 
Millie Das
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Research Funding - Abbvie; Celgene; United Therapeutics; Varian Medical Systems; Verily
 
Kavitha Ramchandran
Consulting or Advisory Role - Drishti
 
Sukhmani Kaur Padda
Consulting or Advisory Role - AstraZeneca; G1 Therapeutics; Pfizer
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); EpicentRx (Inst); Forty Seven (Inst)
 
Joel W. Neal
Honoraria - Biomedical Learning Institute; CME Matters; Medscape; MJH Life Sciences; MLI Peerview; Prime Oncology; Research to Practice; Rockpointe
Consulting or Advisory Role - AstraZeneca; Calithera Biosciences; Exelixis; Genentech/Roche; Jounce Therapeutics; Lilly; Takeda
Research Funding - Adaptimmune (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Up To Date - Royalties
 
Heather A. Wakelee
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Helsinn Therapeutics; Janssen Oncology; Mirati Therapeutics; Xcovery
Research Funding - ACEA Biosciences (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Merck; Takeda
 
Billy W. Loo
Stock and Other Ownership Interests - TibaRay, Inc.
Honoraria - Varian Medical Systems
Research Funding - RaySearch Laboratories; Varian Medical Systems
 
Steven H. Lin
Honoraria - AstraZeneca/MedImmune
Speakers' Bureau - Varian Medical Systems
Research Funding - Genentech/Roche; Hitachi Chemical; New River Labs; STCube Pharmaceuticals Inc.
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed
Consulting or Advisory Role - AstraZeneca; BioNTech; Roche
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems